Learn about the current medication options for managing type 2 diabetes and chronic kidney disease, including SGLT2 ...

Sodium-glucose cotransporter-2 (SGLT-2) inhibitors used to treat type 2 diabetes are associated with an 11% lower risk of ...

Note: The U.S. Food and Drug Administration (FDA) does not approve supplements for safety or effectiveness. Talk to a healthcare professional about whether a supplement is the right fit for your ...

In this study, major adverse cardiovascular event risk varied significantly by medication class, with most protection achieved with sustained treatment with glucagon-like peptide-1 receptor agonists ...

Please provide your email address to receive an email when new articles are posted on . Use of GLP-1 drugs was linked to a 23% lower mortality risk for adults with type 2 diabetes on dialysis. The ...

SEATTLE — Use of GLP-1 receptor agonists (GLP-1s) was associated with a reduction in fragility fractures among older women with type 2 diabetes (T2D) in a retrospective analysis of data from a global ...

Type 2 diabetes is caused by insulin resistance, which often develops over time, and is more likely for certain people.